Clinical Trials
32 trialsPhase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma
Canadian Cancer Trials Group
Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Canadian Cancer Trials Group
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Canadian Cancer Trials Group
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Eastern Cooperative Oncology Group
PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
Eastern Cooperative Oncology Group
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
Eastern Cooperative Oncology Group
Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
Eastern Cooperative Oncology Group
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Eastern Cooperative Oncology Group
Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
Eastern Cooperative Oncology Group
Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome
Eastern Cooperative Oncology Group
SYS-ACT
Cancer Trials Ireland
Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
Canadian Cancer Trials Group
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
SWOG Cancer Research Network
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Cancer Trials Ireland
Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy
Eastern Cooperative Oncology Group
Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma
Eastern Cooperative Oncology Group
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
Eastern Cooperative Oncology Group
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
Eastern Cooperative Oncology Group
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim
Eastern Cooperative Oncology Group
Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
Eastern Cooperative Oncology Group
Collecting Tumor Samples From Patients With Gynecological Tumors
GOG Foundation
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
SWOG Cancer Research Network
Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma
Cancer Trials Ireland
Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
Children's Oncology Group
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
SWOG Cancer Research Network
S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
SWOG Cancer Research Network
E7070 in Treating Patients With Stage IV Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
SWOG Cancer Research Network